Tizanidine Tablet
Product Images NDC 80425-0454

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 80425-0454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine 4mg #30 (Tizanidine 4mg 80425 0454 01)

tizanidine 4 mg oral tablet packaging label from Advanced Rx of Tennessee, LLC. The label compares this product to Zanaflex and includes NDC numbers, lot, and expiration date information (3/31/2026). The label features a bar code and storage instructions at 20°-25°C (68°-77°F).*

FDA Label Image

Tizanidine 4mg #60 (Tizanidine 4mg 80425 0454 02)

Label for tizanidine 4 mg oral tablet by Advanced Rx of Tennessee, LLC, including NDC 80425-0454-02, lot and expiration date (3/31/2026) fields, barcode, and storage instructions at 20°-25°C. Label references comparison to ZANAFLEX.*

FDA Label Image

Tizanidine 4mg #90 (Tizanidine 4mg 80425 0454 03)

Label for tizanidine 4 mg tablets by Advanced Rx of Tennessee, LLC. The label states 'Tizanidine 4MG Tablet #90', with comparison to Zanaflex. Storage instructions specify 20°-25°C (68°-77°F). The label includes caution about prescription transfer, lot number, expiration date 3/31/2026, NDC 80425-0454-03, and a barcode. Manufacturer Viona Pharmaceu is mentioned.*

FDA Label Image

Tizanidine 4mg #120 (Tizanidine 4mg 80425 0454 04)

Label for tizanidine 4 mg tablet by Advanced Rx of Tennessee, LLC. The label includes NDC 80425-0454-04 and references a source NDC. It provides storage instructions at 20°-25°C (68°-77°F) and indicates prescription use only. The lot number and expiration date section are present but not readable.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 01)

Chemical structure of tizanidine hydrochloride, showing the molecular arrangement of atoms including chlorine, nitrogen, sulfur, and hydrogen components.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 02)

A line graph depicting plasma tizanidine concentration (ng/mL) over hours from dosing, comparing four scenarios of 2x 4 mg tizanidine doses: tablets with food, tablets without food, capsules with food, and capsules without food. Concentrations peak between 1 and 3 hours and then decline over 24 hours.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 03)

A line graph showing the improvement in Ashworth scores over time in hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis indicates improvement, while the horizontal axis measures time up to 6 hours. Both tizanidine doses show greater improvement compared to placebo with data points and error bars.*

FDA Label Image

Figure (C1813e2d 81a1 4db6 80a3 12c265d1e8f5 04)

A line graph comparing improvement in Ashworth Score between tizanidine (mean dose 28.8 mg) and placebo groups over three study phases: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The vertical axis represents improvement in Ashworth Score, with tizanidine showing greater improvement than placebo at all time points, including error bars indicating variability.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.